跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,558 条关于
“anti-TIGIT antibody”
全部
26,558
临床试验
12,399
药物
4,645
机构
127
资讯
9,387
去年
iTeos Secures $120M Funding to Advance TIGIT Antibody Program in NSCLC
去年
Novel Anti-TIGIT Therapy Shows Significant Survival Benefit in Advanced Liver Cancer Trial
去年
MSD Discontinues Development of TIGIT and LAG-3 Cancer Immunotherapy Programs
去年
BeiGene Discontinues Ociperlimab Development After Failed Phase III Lung Cancer Trial
2年前
Merck Discontinues Vibostolimab/Pembrolizumab Arm in Phase 3 Melanoma Trial
2年前
GSK and iTeos' Belrestotug Shows Promise in NSCLC Trial, Offering Hope for TIGIT Therapies
3个月前
TIGIT Emerges as a Breakthrough Second-Generation Immune Checkpoint Target to Overcome Cancer Immunotherapy Resistance
去年
GSK and iTeos Halt Development of TIGIT Immunotherapy After Failed Lung Cancer Trial
去年
Merck Forges Ahead with Bispecific Antibody and Oral GLP-1 Agonist, Updates Immuno-oncology Programs
9个月前
Arcus and Gilead Discontinue TIGIT Therapy After Phase III Gastric Cancer Trial Failure
第 1 页,共 939 页
上一页
下一页